New Multiple Sclerosis Drug Insights
New MS drug insights are available to the market now that Vivisum has released its multiple sclerosis library with up-to-date data sourced in between August and
New MS drug insights are available to the market now that Vivisum has released its multiple sclerosis library with up-to-date data sourced in between August and
Excitement is building among gastroenterologists for a handful of ulcerative colitis pipeline drugs currently in development. Etrasimod is one of the drugs causing a stir
5 important reasons biotech branding should be top of mind for new product planning and launch teams. The Essentials of Biotech Branding If you’re a
Vivisum has always striven to pursue meaningful work and explore the role of business in social progress. We can’t think of a better way to
Biotech Brand Building: Message Matrix Every pharmaceutical or biotech product is unique, and marketers must construct marketing communications based on the unique circumstances of their
Over the last two decades, pharmaceutical and biotech marketers have witnessed a rapid evolution in the size and complexity of their audience. Twenty-five years ago,
In this blog series, we are examining competitive context archetypes for biotech and pharmaceutical brands: Archetype 1: First-in-Class Brands Archetype 2: Next Generation Brands Archetype
In this blog series, we are examining competitive context archetypes for biotech and pharmaceutical brands: Archetype 1: First-in-Class Brands Archetype 2: Next Generation Brands Archetype
Yes, launching the a first-of-its-kind product to the market is an entrepreneurial goal. But being first in class has its challenges. Marketing 101 tells us
Sometimes it’s easy to just go along to get along. Much of the time, as market researchers, we are asked by our internal clients (typically
Automated page speed optimizations for fast site performance